Chr. Hansen is a global supplier of bioscience-based ingredients to various industries. In the first half of 2011-2012, Chr. Hansen saw 9% revenue growth and a 19% increase in EBIT. Organic revenue growth was 9% and adjusted to 11% when accounting for changes in carmine raw material prices. Net profit was also up 19% over the same period last year. The company maintains leading market positions through innovative products and processes as well as long-term customer relationships and intellectual property.

1. Quarterly
Chr. Hansen case

2. What was the situation?
What did we do?
How did it work?

3. 3
We are
A global supplier of bioscience based
ingredients to the food, health,
pharmaceutical and agricultural industries
We mainly produce cultures and dairy
enzymes, probiotics and natural colors
Our leading market positions stem from
innovative products and production
processes, long-term customer
relationships and intellectual property
Chr. Hansen scientists

4. 4

5. 5

6. 6

7. 7
Highlights 1H 2011/12
1H 11/12
Organic
growth 9% 19%
1H 10/11
EBIT margin 25% 23%
Organic
growth excl.
carmine price
11% 12%
 Revenue EUR 333 million, up 9%
 Organic revenue growth of 9%
 11% adjusted for change in sales prices to reflect
changes in raw material prices for carmine
 EBIT EUR 83 million, up 19%
 EBIT margin 25%, up from 23%
 Net profit EUR 57 million, up 19%

8. 8

9. 9
Professional, creativeand challengingapproach

10. 10

11. 11

12. 12

13. How did it go?

14. Q & A
14

15. Find and follow us
www.chr-hansen.com
www.chr-hansen.com/youtube
www.chr-hansen.com/linkedin
www.chr-hansen.com/twitter